BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10982343)

  • 1. Characterization of a major histocompatibility complex class II X-box-binding protein enhancing tat-induced transcription directed by the human immunodeficiency virus type 1 long terminal repeat.
    Mischiati C; Feriotto G; Borgatti M; Giacomini P; Gambari R
    J Virol; 2000 Oct; 74(19):8989-9001. PubMed ID: 10982343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA elements target of transcriptional factors are not restricted to long terminal repeat of human immunodeficiency virus.
    Feriotto G; Volinia S; Giacomini P; Gambari R
    Anticancer Res; 1992; 12(1):65-71. PubMed ID: 1567183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.
    Ou SH; Garcia-Martínez LF; Paulssen EJ; Gaynor RB
    J Virol; 1994 Nov; 68(11):7188-99. PubMed ID: 7933101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
    Giacca M; Gutierrez MI; Menzo S; d'Adda di Fagagna F; Falaschi A
    Virology; 1992 Jan; 186(1):133-47. PubMed ID: 1727595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.
    Ou SH; Wu F; Harrich D; García-Martínez LF; Gaynor RB
    J Virol; 1995 Jun; 69(6):3584-96. PubMed ID: 7745706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
    Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
    J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL; Sharma PL; Crumpacker CS
    Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
    Zeichner SL; Kim JY; Alwine JC
    J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions.
    Oelze I; Rittner K; Sczakiel G
    J Virol; 1994 Feb; 68(2):1229-33. PubMed ID: 8289357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes.
    Wilhelm E; Doyle MC; Nzaramba I; Magdzinski A; Dumais N; Bell B
    Retrovirology; 2012 Jul; 9():62. PubMed ID: 22834489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
    J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
    Hasegawa SL; Boss JM
    Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
    Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W
    Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
    Roebuck KA; Brenner DA; Kagnoff MF
    J Clin Invest; 1993 Sep; 92(3):1336-48. PubMed ID: 8376588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.